2020 - Best financial year so far (preliminary business figures)

Geratal, March 23, 2021: Geratherm Medical AG (ISIN: DE0005495626) had a very good performance, especially in the last 9 months of 2020 financial year. Sales increased by +38.4%. The result from ordinary business operations clearly increased to more than double.

All product segments had a strong increase in sales. Healthcare Diagnostic EUR 18.4 million, +40.1%; Respiratory EUR 4.8 million, +14.2%; Medical warming systems EUR 2.4 million, +184.2%; Cardio/Stroke 1.9 million EUR, +11.0%.

  • Revenues EUR 27.5 million +38.4%
  • EBITDA 4,347 kEUR + 84.7%
  • EBITDA-Margin 15.8% + 32.8%
  • Operating profit (EBIT) 3,039 kEUR +189.7%
  • result from ordinary operations 2,719 kEUR +161.9%
  • Earnings per share 41 cents (previous year: 11 cents)
  • Return on equity 10.3% • Equity ratio 55.4%
  • Cash and securities EUR 10.3 million
  • Proposed dividend: 40 cents per share 
  • Still strong international demand for Geratherm medical products

The detailed Annual Report 2020 will be published on April 28, 2021.

Publication of insider information in accordance with Article 17 MAR, transmitted by DGAP - a service of EQS-Group AG

Back